RandallAlanOyerMD

Clinical Trials

• A Phase II Prospective Trial Correlating Progression Free Survival With CYP2D6 Activity in Patients With Metastatic Breast Cancer Treated With Single Agent Tamoxifen Start of enrollment: 2010 Sep 01Alden, M.,Atkins, J.N.,Bayer, G.K.,Behrens, R.J.,Berenberg, J.L.,Carolla, R.L.,Chew, H.K.,Dakhil, S.R.,Dean-Colomb, W.,Entmacher, M.S.,Erban, J.K.,Gross, H.M.,Jubelirer, S.J.,Kirschling, R.J.,Klein, P.,Le...
• Randomized Phase III Study of Maintenance Therapy With Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC Start of enrollment: 2010 Aug 01Arcenas, A.G.,Atkins, J.N.,Axelrod, R.S.,Beeker, T.A.,Behrens, R.J.,Belani, C.P.,Brandes, J.C.,Busiek, D.F.,Butala, A.,Canfield, V.A.,Carolla, R.L.,Chitneni, S.R.,Clarkson, J.E.,Colman, L.K.,Conklin, R.J....
• A Phase III Randomized Trial of Metformin Versus Placebo on Recurrence and Survival in Early Stage Breast Cancer Start of enrollment: 2010 Jul 01Abraham, J.,Adelson, K.,Al-Jazayrly, G.,Andersen, J.,Anderson, J.,Angevine, A.,Ardman, B.,Arnold, F.P.,Atkins, J.,Averbook, B.,Baar, J.,Bajaj, R.,Bascom, G.,Behrens, R.,Berenberg, J.,Bernstein, V.,Bin, J....
• A Phase III Trial of 6 Versus 12 Treatments of Adjuvant FOLFOX Plus Celecoxib or Placebo for Patients With Resected Stage III Colon Cancer Start of enrollment: 2010 Jun 01(Gbenga), O.O.,Advani, A.S.,Agarwala, S.S.,Ahmed, S.,Al-Hazzouri, A.,Ansari, R.H.,Ardman, B.,Asik, A.,Atkins, J.N.,Averbook, B.J.,Aziz, S.,Bar-Lev, A.,Barhamand, F.B.,Bathini, V.G.,Behrens, R.J.,Benson, A...
• A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMCA12 for Patients With Extensive Stage Small Cell Lung Cancer Start of enrollment: 2009 Jul 01Ballas, M.S.,Behrens, R.J.,Belani, C.P.,Blankstein, K.B.,Constantinou, C.L.,Dakhil, S.R.,DeShields, M.S.,Dowell, J.,Eisner, R.M.,Ellerton, J.A.,Eskander, E.,Flynn, P.J.,Friedman, E.L.,Gilman, P.B.,Harris,...
• Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2009 Apr 01Abitbol, A.A.,Behrens, R.J.,Bierman, P.J.,Bristol, I.J.,Buchbarker, D.,Castillo-Perez, J.G.,Chang, B.K.,Chao, S.T.,Chen, Y.,Clarkson, J.E.,Constantinou, C.L.,Cooley, G.M.,Crocker, I.R.,Dakhil, S.R.,Dardic...
• A Phase III Trial of Irinotecan / 5-FU / Leucovorin or Oxaliplatin / 5-FU/ Leucovorin With Bevacizumab, or Cetuximab (C225), or With the Combination of Bevacizumab and Cetuximab for Patients With Untreated Metastatic Adenocarcinoma of the Colon or Rectum Start of enrollment: 2005 Nov 01Advani, A.S.,Ahmed, S.,Alden, M.,Anglin, P.J.,Ansari, R.H.,Atkins, J.N.,Averbook, B.J.,Aziz, S.,Baez-Diaz, L.,Bank, B.B.,Barai, B.H.,Barhamand, F.B.,Bearden, J.D.,Beeker, T.A.,Behrens, R.J.,Berenberg, J.L...